(Q46728895)

24 December 2017

title

Hormonal chemoprevention of cancer in women (English)

1 reference

24 December 2017

B E Henderson

1 reference

24 December 2017

R K Ross

1 reference

24 December 2017

M C Pike

series ordinal

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

24 December 2017

published in

Science

1 reference

24 December 2017

volume

259

1 reference

24 December 2017

issue

5095

1 reference

24 December 2017

page(s)

633-638

1 reference

24 December 2017

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Menopausal oestrogens and breast cancer risk: an expanded case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

The epidemiology of endometrial cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Toward the primary prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Estrogens and Endometrial Cancer in a Retirement Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Potential role of tamoxifen in prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

The association of replacement estrogens with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Indomethacin, ranitidine, and interleukin-2 in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Oral contraceptives in the United States: trends in content and potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

The effect of age and menstrual cycle upon proliferative activity of the normal human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Association of Exogenous Estrogen and Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

A randomized comparison of nonoral estradiol delivery in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.8381558

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.8381558

1 reference

24 December 2017

1 reference

24 December 2017